MBXBF (Microbix Biosystems) Ending Cash Position: $5.93 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBXBF Microbix Biosystems Inc MBXBF
56 GF Score
Price $0.22
GF Value $0.19
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Ending Cash Position?

Microbix Biosystems MBXBF +0.47% 56 Ending Cash Position is $5.93 Mil as of Mar. 2026. GuruFocus rates MBXBF with a GF Score™ of 56/100 and a GF Value™ of $0.19 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Microbix Biosystems's Ending Cash Position for the quarter that ended in Mar. 2026 was $5.93 Mil.

Microbix Biosystems's quarterly Ending Cash Position declined from Sep. 2025 ($8.76 Mil) to Dec. 2025 ($6.60 Mil) and declined from Dec. 2025 ($6.60 Mil) to Mar. 2026 ($5.93 Mil).

Microbix Biosystems's annual Ending Cash Position increased from Sep. 2023 ($8.58 Mil) to Sep. 2024 ($9.57 Mil) but then declined from Sep. 2024 ($9.57 Mil) to Sep. 2025 ($8.76 Mil).

Microbix Biosystems Ending Cash Position Related Terms

Microbix Biosystems Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Ending Cash Position Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.88 10.11 8.58 9.57 8.76

Microbix Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.58 8.85 8.76 6.60 5.93
MBXBF
56GF Score
Microbix Biosystems Inc MBXBF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Microbix Biosystems's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9.37+-0.614
=8.76

Microbix Biosystems's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=6.631+-0.705
=5.93

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $5.93 Mil mean?
Microbix Biosystems (MBXBF) has a Ending Cash Position of $5.93 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Ending Cash Position too high?
Microbix Biosystems' current Ending Cash Position is $5.93 Mil. Overall, Microbix Biosystems has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Ending Cash Position compare to VRTX and REGN?
Microbix Biosystems' Ending Cash Position of $5.93 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Ending Cash Position is $5.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.19, compared to a current price of $0.22 — trading 15.8% above its estimated fair value. The current Ending Cash Position is $5.93 Mil. Microbix Biosystems' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Ending Cash Position is $5.93 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 15.8% above its estimated GF Value™ of $0.19. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Ending Cash Position: $5.93 Mil
  • GF Value™: $0.19 vs. price of $0.22 (15.8% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
56GF Score

Get the complete analysis for MBXBF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.19
GF Value